Senores Pharmaceuticals IPO lists at 53% premium
The company's portfolio includes 21 commercialized products, 19 approved ANDAs, 4 CGT designations, 6 filed ANDAs, and 45 products in its pipeline
The company's portfolio includes 21 commercialized products, 19 approved ANDAs, 4 CGT designations, 6 filed ANDAs, and 45 products in its pipeline
The product will be marketed by Dr. Reddy's
Chobhe brings over 30 years of extensive experience in quality and regulatory management within the pharmaceutical industry
Sanofi India has reported total income of Rs. 738.9 crores during the period ended March 31, 2024
Earlier, he worked with Cadila Pharmaceuticals Limited, Cipla, Alkem Laboratories, and Wockhardt, and started his career with Novartis
InvaGen has received 5 inspectional observations in Form 483
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
Subscribe To Our Newsletter & Stay Updated